Inventor
KUBOTA TSUGUO
JP18 patents
⚠️ This page may combine multiple inventors who share the name “KUBOTA TSUGUO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KYOWA HAKKO KIRIN CO LTD
7 patentsUS9207238B2Dec 8, 2015
Anti-FOLR1 antibody
KYOWA HAKKO KIRIN CO LTD29 citations91
US9556270B2Jan 31, 2017
Anti-TIM-3 antibody
KYOWA HAKKO KIRIN CO LTD17 citations90
US8673592B2Mar 18, 2014
Anti system ASC amino acid transporter 2 (ASCT2) antibody
KYOWA HAKKO KIRIN CO LTD9 citations83
US10550181B2Feb 4, 2020
Anti-TIM-3 antibody
KYOWA HAKKO KIRIN CO LTD5 citations82
US9695237B2Jul 4, 2017
Anti-FOLR1 antibody
KYOWA HAKKO KIRIN CO LTD4 citations70
US9181332B2Nov 10, 2015
Anti-A(β) oligomer humanized antibody
KYOWA HAKKO KIRIN CO LTD3 citations63
US8969040B2Mar 3, 2015
Pharmaceutical agent comprising anti-BMP9 antibody as active ingredient for treatment of anemia such as renal anemia and cancer anemia
KYOWA HAKKO KIRIN CO LTD1 citations51
KUBOTA TSUGUO
4 patentsUS9403914B2Aug 2, 2016
Anti-CD27 humanized monoclonal antibody
KUBOTA TSUGUO21 citations91
US8501180B2Aug 6, 2013
Anti system ASC amino acid transporter 2 (ASCT2) antibody
KUBOTA TSUGUO7 citations82
US8333967B2Dec 18, 2012
Anti-Aβ oligomer humanized antibody
KUBOTA TSUGUO2 citations62
US8303954B2Nov 6, 2012
Anti-Aβ oligomer humanized antibody
KUBOTA TSUGUO4 citations62